Novel Foxo1-dependent transcriptional programs control Treg cell functionWeiming Ouyang, Ming O. Li, Will Liao et al.|Nature|2012Cited by 406
Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug SelectionAndrew G. Polson, Allen Ebens, Gladys S. Ingle et al.|Cancer Research|2009Cited by 248
The Wnt Antagonist Dickkopf-1 Promotes Pathological Type 2 Cell-Mediated InflammationWook‐Jin Chae, Alfred L.M. Bothwell, Allison Ehrlich et al.|Immunity|2016Cited by 131
The TAM family receptor tyrosine kinase TYRO3 is a negative regulator of type 2 immunityPamela Chan, Carla V. Rothlin, Eugenio Antonio Carrera Silva et al.|Science|2016Cited by 93
Neutral or Detrimental Effects of TREM2 Agonist Antibodies in Preclinical Models of Alzheimer’s Disease and Multiple SclerosisAinhoa Etxeberría, Christopher J. Bohlen, Yun‐An Shen et al.|Journal of Neuroscience|2024Cited by 28